13F-HR filed by Sands Capital Alternatives, LLC
Sands Capital Alternatives, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 18 holding rows worth $478,657,000.
- Accession
- 0001567619-22-010358
- Filer
- CIK 1846444
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 18 entries on the cover page, a total value of $478,657,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $478,655,000 with VALUE read as thousands by filing date, 13F file number 028-21032. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UIPATH INC | 90364P105 | CL A | 3,811,779 | $82,296,000 | thousands by filing date | |
| NU HLDGS LTD | G6683N103 | ORD SHS CL A | 9,136,835 | $70,536,000 | thousands by filing date | |
| DOORDASH INC CL A | 25809K105 | Stock | 601,454 | $70,484,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 3,148,970 | $60,240,000 | thousands by filing date | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 214,621 | $49,176,000 | thousands by filing date | |
| SAMSARA, INC. | FDS1Q2O30 | COM CL B | 2,712,256 | $43,450,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 267,895 | $33,966,000 | thousands by filing date | |
| CINCOR PHARMA INC | 17240Y109 | COM | 950,000 | $16,663,000 | thousands by filing date | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 3,417,075 | $13,361,000 | thousands by filing date | |
| OLINK HLDG AB | 680710100 | ADR | 425,514 | $7,515,000 | thousands by filing date | |
| 908 DEVICES INC COM | 65443P102 | Stock | 326,427 | $6,205,000 | thousands by filing date | |
| SAMSARA INC COM CL A | 79589L106 | Stock | 326,000 | $5,223,000 | thousands by filing date | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 724,873 | $4,726,000 | thousands by filing date | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 260,000 | $4,373,000 | thousands by filing date | |
| REPLIGEN CORP COM | 759916109 | Stock | 22,544 | $4,240,000 | thousands by filing date | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 811,737 | $4,132,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 787,007 | $1,582,000 | thousands by filing date | |
| ABSCI CORPORATION | 00091E109 | COM | 57,804 | $487,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-010358 | this filing | 2022-05-13 | acceptance time not in the bulk data set |